Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UROV | AMGN | BMY | VRTX | GILD |
| Company | Urovant Sciences Ltd | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 16.23 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 16.24 | 288.83 | 58.22 | 455.43 | 89.07 |
| Low | 16.21 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 16.24 | 285.68 | 57.86 | 446.85 | 88.49 |
| Change | +0.01 | -2.19 | -0.02 | -4.38 | -0.14 |
| % Change | +0.06% | -0.76% | -0.03% | -0.97% | -0.16% |
| Volume | 1,739,000 | 295,037 | 915,995 | 144,909 | 434,049 |
| 20-Day Average Volume | 143,510 | 2,753,223 | 12,051,875 | 1,272,419 | 7,335,656 |
| Previous Close | 16.23 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.21 | 307.22 | 55.90 | 479.02 | 90.81 |
| 20-Day Raw Stochastic | 87.10% | 19.81% | 63.54% | 1.00% | 15.91% |
| 20-Day Relative Strength | 65.56% | 34.04% | 59.31% | 39.72% | 49.81% |
| Weighted Alpha | +6.45 | +0.04 | +24.48 | +16.45 | +22.90 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 96% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/19/21 | -3.36% since 11/14/24 | -1.37% since 11/14/24 | -7.84% since 11/14/24 | -4.33% since 11/14/24 |
| Low | 16.20 on 03/24/21 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.25 on 11/21/24 | 86.08 on 11/19/24 |
| High | 16.25 on 03/25/21 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +0.43% since 02/26/21 | -9.71% since 10/21/24 | +10.71% since 10/21/24 | -6.71% since 10/21/24 | +2.12% since 10/21/24 |
| Low | 16.10 on 03/02/21 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.25 on 11/21/24 | 85.60 on 10/22/24 |
| High | 16.26 on 03/19/21 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +1.25% since 12/24/20 | -13.11% since 08/21/24 | +19.12% since 08/21/24 | -8.25% since 08/21/24 | +17.29% since 08/21/24 |
| Low | 16.03 on 12/30/20 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.25 on 11/21/24 | 75.35 on 08/22/24 |
| High | 16.26 on 03/19/21 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +76.14% since 09/25/20 | -9.16% since 05/21/24 | +36.50% since 05/21/24 | +0.90% since 05/21/24 | +30.96% since 05/21/24 |
| Low | 7.15 on 11/02/20 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 16.26 on 03/19/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 531,746 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 32,743 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -146,750,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -46,800,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 2.35 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 02/11/21 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |